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Implication for health policy/practice/research/medical education:
Caffeic acid phenethyl ester (CAPE) can effectively inhibit cell proliferation in gastric cancer cell line and might be useful in the 
treatment of patients with gastric cancer.
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Introduction: Up-regulation of phospholipase D (PLD) is functionally related to tumorigenesis 
and oncogenic signals. Chrysin, caffeic acid phenethyl ester (CAPE) and ethanolic extract of 
propolis (EEP) are three safe compounds which have been shown to possess antiproliferative, 
antioxidant, anti-inflammatory and antineoplastic properties. In this study, the effects of 
these three compounds on PLD1 gene expression were examined in AGS cell line. 
Methods: After determining the appropriate concentrations of EEP, CAPE, and chrysin, 
AGS cells were cultured in mediums with proper ratios of the compounds. AGS cells were 
maintained in exponential growth and the culture mediums refreshed every other day. 
Finally, after extracting total RNA from AGS cells, real-time PCR was performed to evaluate 
the mRNA expression of PLD1 in the presence of each compound.
Results: CAPE decreased the mRNA level of PLD1 gene in a dose-dependent manner. A 
solution with 30 µM concentration of CAPE was the effective dose in comparison to control 
group as well as 15 and 20 µM concentrations of the compound, whereas no changes were 
observed in the presence of EEP and chrysin.
Conclusion: Taken together, the results of the study indicated that CAPE might exert its anti-
neoplastic effect by targeting PLD1 expression in AGS cell line.
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A B S T R A C T
Introduction
On the molecular level, various factors can have effects 
on incidence and progression of cancers, including 
environmental factors, epigenetics and changes in specific 
genes expression (1-3). In many cancers, chemotherapy 
resistance is a common phenomenon and the major 
limitation in their treatment (4). Therefore, finding new 
ways and approaches to improve the life quality of patients 
with cancer or treating them, is quite crucial. Dietary 
supplements or alternatives to medication have become 
increasingly popular and the main focus to improve nature-
based compounds with chemopreventive properties (5, 6). 
Chrysin, caffeic acid phenethyl ester (CAPE) and ethanolic 
extract of propolis (EEP) are three safe compounds and 
potential adjuvant therapies for patients with advanced 
cancers (7). CAPE is a polyphenolic compound which 
has influence on some of the cellular processes, including 
cell survival and proliferation (8). Chrysin and EEP are 
two active compounds that can be found in honey. These 
three compounds are considered to possess antitumor 
properties (7). It has been shown that they have influence 
on some important cell activities such as proliferation, 
apoptosis, and viability, in some cancer cell lines. They 
can exert their anticancer effects through several signaling 
pathways and genes (9, 10). Phospholipase D (PLD) is a 
member of phospholipase enzymes superfamily with two 
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major isoforms, including PLD1and PLD2. Phospholipase 
D1 catalyzes the hydrolysis of phosphatidylcholin which 
leads to production of phosphatidic acid and free choline. 
PLD1 gene and its protein product become activated in 
some cancer cell lines, such as gastric cancer (11). Studies 
in glioma cells confirmed that the overexpression of PLD 
increases invasion via elevating MMP-2 gene transcription 
through NF-kB mediated signaling pathways (12). In the 
present study, by using real time PCR, the effects of CAPE, 
EEP, and chrysin compounds on PLD1 gene expression 
were analyzed in human gastric cancer cell line (AGS cell 
line).
Materials and methods
Chemicals and reagents
Trypsin-EDTA, DMEM, fetal bovine serum (FBS), and 
penicillin-streptomycin were purchased from Gibco Co 
(Invitrogen, Carlsbad, CA, USA). DMSO, CAPE and 
chrysin were purchased from Sigma Chemical Co. (St. 
Louis, MO, USA). Ethanolic extract of propolis (EEP) 
obtained from fresh propolis samples collected from 
Dinaran area (Iran) (13). Other materials and chemical 
reagents used to conduct this study were purchased from 
laboratory reagents providers in Iran. MTT test was 
previously carried out to determine the concentration of 
the compounds in which the cells viability was normal and 
had no effect on the cytotoxicity assays (13, 14). The test 
reagents were dissolved to prepare three stock solutions in 
DMSO for each compound (CAPE 100 µM, chrysin 100 
µM, and EEP 100 µg/mL), and stored in aliquots at -20°C. 
They were diluted with fresh culture medium before use 
and added to the micro-plates at specific concentrations. 
Cell line and cell culture conditions
AGS cell line was purchased from Royan Institute, Tehran, 
Iran. The cells were maintained at exponential growth at 
37°C, in DMEM, supplemented with heat inactivated 10% 
FBS and exposure to 5% CO2. Moreover, penicillin and 
streptomycin 1% were added to the culture medium. The 
culture medium of the cells renewed every second day.
Cell growth assay
The growth characteristics of the AGS cell lines were 
previously described by Amini-Sarteshnizi et al. (13, 14).
RNA extraction and qRT-PCR
Total cellular RNA was extracted from AGS cells treated 
with increasing doses of EEP, CAPE, and chrysin (10,15,30 
µM for CAPE, 20, 30, and 40 µg/mL for EEP, and 15, 20, 
and 30 µM for chrysin) after 72 hours, using Biozol Total 
RNA Extraction Reagent kit (Qiagen, Germany). RNA 
was quantified with a nanodrop 1000 spectrophotometer. 
The purity of the extracted RNA was demonstrated 
using 260/280 and 260/230 wavelength ratios, which are 
commonly in the range of 1.8-2.2. cDNA synthesis was 
conducted by using moloney murine leukemia virus 
(MMLV) reverse transcriptase (Fermentas, Vilnius, 
Lithuania) with oligo-dT primers. qRT-PCR for PLD1 and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
transcripts were performed using specific primers. The 
thermal cycle consisted of an initial denaturation step 
at 95°C for 10 minutes, followed by 45 amplification 
cycles consisting of denaturation at 95°C for 15 seconds, 
annealing at 60°C for 20 seconds, and an extension at 72°C 
for 25 seconds. The PCR products were isolated by agarose 
gel electrophoresis, colored with ethidium bromide, and 
became visible under the ultraviolet light. To evaluate the 
effects of CAPE, chrysin, and EEP on PLD1 expression in 
AGS cells, relative quantitative PCR and comparative Ct 
methods, using Maxima SYBR Green/Rox QPCR Master 
Mix (2X) kit (Fermentase), were performed and analyzed 
on Rotor-Gene 3000 (Corbett Robotics, Australia). All 
tests were carried out at least in triplicate (100 ng total RNA 
per well). Template control was run in each experiment. 
The primer sequence of PLD1 and GAPDH are listed in 
Table 1. Relative mRNA levels of the target gene in each 
sample were normalized to its GAPDH content: Ratio= 
(Etarget) ΔCt target (control−treatment)/ (Ereference) 
ΔCt reference (control−treatment) (15,16). 
Statistical analysis
Data on the cell populations with different treatments and 
conditions were analyzed using GraphPad Prism software 
(v5.01, USA) and Kruskal-Wallis test followed by post-
hoc comparisons and Dunn’s multiple comparison.
Results
Growth characteristics of AGS cell line and optimization 
of qRT-PCR
The growth characteristics of the AGS cell line were 
previously described (13,14). Prior to the quantitative 
analysis, optimization procedures were carried out for 
qRT-PCR on the EEP, chrysin, and CAPE treated AGS 
cell lines. Using specific primers for human PLD1 and 
Table 1. The sequence of the designed primers for amplification of the target genes for qRT-PCR
Target gene Primer sequence Size of the amplicon
Phospholipase D1 (PLD1) 5'-GCTGGGAAAGCGTGACAGTGA-3'5'-AGCCAAGGACAACCCTAAAGCAG-3' 150bp
glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH)
5'-GTGAAGGTCGGAGTCAAC-3'
5'-GTTGAGGTCAATGAAGGG-3' 112bp
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GAPDH genes, electrophoresis of the PCR products was 
conducted on acrylamide gel which demonstrated single 
bands with the expected sizes for amplified PLD1 (150 
bp) and GAPDH (112 bp) segments. Expression analysis 
of the genes showed a unique melting curve without any 
primer dimer for all the inspected genes (Figure 1), which 
was further confirmed by acrylamide gel separation and 
staining. Standard curve was plotted for consistent real-
time PCR results (Figure 1).
Expression of PLD1 gene in AGS cell specimens
After optimization of qRT-PCR, the effects of CAPE, 
chrysin, and EEP on PLD1 gene expression (mRNA) were 
investigated. CAPE decreased the mRNA level of PLD1 
gene in a dose-dependent manner, in comparison with the 
control in the AGS cell line (P = 0.04) whereas no change 
was observed in the presence of EEP (P = 0.3) and chrysin 
(P = 0.08) in this cell line (Figure 2).
Discussion
The current study is the first to show the effects of 
CAPE, chrysin, and EEP on PLD1 gene regulation in the 
AGS cell line. According to our results, CAPE (with the 
concentrations of 30 µM) down-regulated the expression 
Figure 1. Optimization of quantitative RT-PCR (qRT-PCR).  A unique melting curve without primer dimers showing specific amplification of glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) (a) and phospholipase D1 (PLD1) (c) on qRT-PCR. Standard curves of a cDNA dilution series for determination of 
amplification efficiencies of PLD1 (b) and GAPDH (d).
(a)
(b)
(c)
(d)
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of PLD1 gene and subsequently inhibited the proliferation 
of gastric cancer cell  lines. CAPE is a potent antioxidant 
agent isolated from honeybee hive propolis. Several 
studies have shown that CAPE has the potential for the 
treatment of several cancers (17). The compound has 
already been reported to suppress the cell proliferation of 
prostate cancer cell lines (18). A study showed that CAPE 
down-regulated PLD1 expression at the transcriptional 
level and suppressed the proliferation of glioma cells 
(19). Accordingly, the inhibition of PLD1 activity may 
occur via direct binding of the catechol moiety in CAPE 
to cysteine 837 in the PLD1 (19,20). Therefore, this 
study confirmed the evidence on the down-regulation 
Figure 2. Effects of caffeic acid phenethyl ester (CAPE) (a), chrysin (b), 
and ethanolic extract of propolis (EEP) (c) on expression of PLD1 gene 
in AGS cell lines. 
Data are expressed as mean ± standard deviation; * P < 0.05 compared 
with the corresponding value of control group.
of PLD1 gene by CAPE. The phospholipase superfamily 
is defined by a conserved catalytic site and a common 
transphosphatidylation activity at phosphodiester 
bonds. Studies have reported that PLD1 promoted RAS 
and ERK activation and transformation in epithelial 
cells via interaction with PEA-1S (20). Another study 
demonstrated that PLD1 was required for NF-kB 
activation, due to inducing the activation and expression 
of MMP2, and promoted the invasion of the glioma cells 
(21). Rebamipide down-regulates the expression and 
enzymatic activity of PLD1 and inhibits the proliferation 
of gastric cancer cells. A study reported that rebamipide 
inhibited the transactivation of NF-kB in the AGS and 
MKN-1 gastric cancer cells. Such PLD1 suppression may 
be due to the inhibition of NF-kB activity by rebamipide 
(22). 
Chrysin, a naturally occurring flavone, which is found 
in honey and plant extracts, has been shown to possess 
anticancer properties (23). Chrysin exerts its effects 
through the selective modulation of multiple cell signaling 
pathways which are related to the survival, inflammation 
and metastasis of cancer cells. Chrysin is able to kill cancer 
cells of several histotypes including hematologic, lung, 
colon, liver, and breast cancers as well as glioblastoma. 
Chrysin was found to significantly sensitize the TNF-
alpha-induced apoptosis in human colorectal cancer cell 
line HCT-116, human nasopharyngeal carcinoma cell line 
CNE-1, and human liver cancer cell line HEPG2; in which 
such sensitization is closely related to inhibitory effect on 
NF-kB activation (24). On the other hand, NF-kB binds 
to and activates the PLD1 promoter; therefore, chrysin is 
likely to exert its anticancer activity through PLD1 down-
regulation (19). EEP is one of the sources of phenolic 
acids and flavonoids. Several mechanisms were offered 
to explain the overall cancer-preventive and antitumor 
effects of propolis and its phenolic components (25). A 
study reported that EEP inhibited the growth and induced 
apoptosis in HeLa cancer cell line in a dose-dependent 
manner (25). In the present study, however, no correlation 
between EEP or chrysin and PLD1 gene expression was 
observed. It can be hypothesized that EEP and chrysin 
may exert their effects on the protein activity of PLD1. 
PEA-1S, a binding partner of PLD1, promotes H-RAS-
mediated cell transformation via the enhanced expression 
and activation of PLD1 (20). It is likely that PEA-1S 
inhibits the effects of EEP and chrysin.
Conclusion
The results of this study indicated that CAPE might be 
associated with anti-cancer outcome by targeting PLD1 
in the AGS cell line. This study showed that CAPE 
influenced on PLD1 gene expression and down-regulated 
its expression in a dose-dependent manner. Therefore, 
it can be proposed that we may be able to use CAPE as 
an adjuvant therapy for gastric cancer. However, we 
(a)
(b)
(c)
Journal of Herbmed Pharmacology, Volume 8, Number 4, October 2019            http://www.herbmedpharmacol.com312 
Jafari-Ghahfarokhi et al
recommend further research to evaluate PLD1 protein 
activity, so that more definite arguments can be made on 
the effects of the CAPE on PLD1 expression. Regarding 
chrysin and EEP, although no association between them 
and PLD1 expression was observed, research on the effect 
of these two compounds on the translation and activity of 
the PLD1 protein may show promising results and enable 
us to introduce more effective therapies for different 
cancers.
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